Search research articles
Contact Us
Filters
Showing results (1-10 of 239) with videos related to
Page
of 24
Sort By:
Biological & Pharmaceutical Bulletin
|
June 13, 2012
Tributylhexadecylphosphonium bromide, a novel nuclear factor of activated T cells signaling inhibitor, blocks interleukin-2 induction associated with inhibition of p70 ribosomal protein S6 kinase phosphorylation
Hiroshi Umehara, Akira Asai
Methods in Molecular Biology (Clifton, N.J.)
|
January 17, 2017
Alpha-Based Multiplexed Assay for Identifying SH2 Domain Antagonists
Akira Asai, Kazuyuki Takakuma
Methods in Molecular Biology (Clifton, N.J.)
|
January 17, 2017
Expression and Purification of Soluble STAT5b/STAT3 Proteins for SH2 Domain Binding Assay
Akira Asai, Kazuyuki Takakuma
The Journal of Nutrition
|
August 31, 2004
An epoxide-furanoid rearrangement of spinach neoxanthin occurs in the gastrointestinal tract of mice and in vitro: formation and cytostatic activity of neochrome stereoisomers
Akira Asai, Masaru Terasaki, Akihiko Nagao
Nutrients
|
November 26, 2022
The Significance of Zinc in Patients with Chronic Liver Disease
Hiroki Nishikawa, Akira Asai, Shinya Fukunishi
The British Journal of Nutrition
|
January 12, 2008
Low bioavailability of dietary epoxyxanthophylls in humans
Akira Asai, Lina Yonekura, Akihiko Nagao
Journal of Diabetes Investigation
|
May 21, 2014
FoxO1 breaks diabetic heart
Mototsugu Nagao, Akira Asai, Shinichi Oikawa
Physiological Reports
|
October 28, 2020
STX-0119, a novel STAT3 dimerization inhibitor, prevents fibrotic gene expression in a mouse model of kidney fibrosis by regulating Cxcr4 and Ccr1 expression
Kouki Makitani, Naohisa Ogo, Akira Asai
Cancer Letters
|
March 2, 2005
Neoxanthin and fucoxanthin induce apoptosis in PC-3 human prostate cancer cells
Eiichi Kotake-Nara, Akira Asai, Akihiko Nagao
International Journal of Molecular Sciences
|
January 23, 2024
Body Composition in Chronic Liver Disease
Hiroki Nishikawa, Soo Ki Kim, Akira Asai
Page
of 24
Search research articles
Search
Showing results (1-10 of 239) with videos related to
Sort By:
Page
of 24
Biological & Pharmaceutical Bulletin
|
June 13, 2012
Tributylhexadecylphosphonium bromide, a novel nuclear factor of activated T cells signaling inhibitor, blocks interleukin-2 induction associated with inhibition of p70 ribosomal protein S6 kinase phosphorylation
Hiroshi Umehara, Akira Asai
Methods in Molecular Biology (Clifton, N.J.)
|
January 17, 2017
Alpha-Based Multiplexed Assay for Identifying SH2 Domain Antagonists
Akira Asai, Kazuyuki Takakuma
Methods in Molecular Biology (Clifton, N.J.)
|
January 17, 2017
Expression and Purification of Soluble STAT5b/STAT3 Proteins for SH2 Domain Binding Assay
Akira Asai, Kazuyuki Takakuma
The Journal of Nutrition
|
August 31, 2004
An epoxide-furanoid rearrangement of spinach neoxanthin occurs in the gastrointestinal tract of mice and in vitro: formation and cytostatic activity of neochrome stereoisomers
Akira Asai, Masaru Terasaki, Akihiko Nagao
Nutrients
|
November 26, 2022
The Significance of Zinc in Patients with Chronic Liver Disease
Hiroki Nishikawa, Akira Asai, Shinya Fukunishi
The British Journal of Nutrition
|
January 12, 2008
Low bioavailability of dietary epoxyxanthophylls in humans
Akira Asai, Lina Yonekura, Akihiko Nagao
Journal of Diabetes Investigation
|
May 21, 2014
FoxO1 breaks diabetic heart
Mototsugu Nagao, Akira Asai, Shinichi Oikawa
Physiological Reports
|
October 28, 2020
STX-0119, a novel STAT3 dimerization inhibitor, prevents fibrotic gene expression in a mouse model of kidney fibrosis by regulating Cxcr4 and Ccr1 expression
Kouki Makitani, Naohisa Ogo, Akira Asai
Cancer Letters
|
March 2, 2005
Neoxanthin and fucoxanthin induce apoptosis in PC-3 human prostate cancer cells
Eiichi Kotake-Nara, Akira Asai, Akihiko Nagao
International Journal of Molecular Sciences
|
January 23, 2024
Body Composition in Chronic Liver Disease
Hiroki Nishikawa, Soo Ki Kim, Akira Asai
Page
of 24